BullRyder's  Instablog

Send Message
  • VPRO,Viropro,DSTI,Day Star Technologies,CTIC,Cell Therapeutics 1 comment
    Feb 25, 2011 2:52 PM | about stocks: CTIC, EPIC

    Hot Stock Picks Friday 02-25-11

    VPRO - Viropro, an emerging Biotech Pharmaceutical company focused on Generic Drugs.

    Recently made a major acquisition. Highly Speculative.

    DSTI – Daystar Technologies, huge swings in oil in recent days make sense to look at this small solar play.

    CTIC – Cell Therapeutics, after a huge drop attracting speculative players, keep an eye.


    Get Alerts that MakeMoney!® Everything else:HOTair©

    Disclosure:Remember we are NOT a Non-Profit organization, we receive compensation from the companies we feature on our website(s), Blog(s) and Email Alerts. Read full disclosure/disclaimer. Thanks
    OxBridge Research



    Stocks: CTIC, EPIC
Back To BullRyder's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (1)
Track new comments
  • deeppocketsgolf
    , contributor
    Comments (111) | Send Message


    Announcing Name Change @ Next Meeting of Shareholders;


    Development Stage Since July-2003; however has not reported financials since May-10;


    Per Last Equity Reported (459,299K) and with the addition of the following criteria;


    Report a PROForma Fwd Net Loss of (1.763_656M); Per Next Report; [In line with Development Stage Expenses, Since ‘03]


    What would the company look like??? @ .06 or 6 Cents;;


    Report Category, ,Notes, Report, Price, , Metric, , Weight, , Primary Weight Adj Trading Metric, ,Year / Desig/ DAY Weight Adj Price.


    20. Deficit, (16.08) ,M, 10-Q 0.06 , (0.63) , 0.9 , (0.57548) , July 2011, 0.06


    21. Paid In Equity, 15.6 ,M, 10-Q 0.06 , 0.6472 , 0.8 , 0.5393 , July 2011, 0.05


    22. Preferred, 0 ,M, 10-Q 0.06 , 0 , 1.0 , 0 , July 2011, 0.06


    23. Common / Other, 0.0224 ,M, 10-Q 0.06 , 452 , 0.9 , 403 , July 2011, 0.05


    24. Report a Fwd Net Loss (1.763_656) ,M, 10-Q 0.06 , (5.724664) , 0.9 , (5.343) , July 2011, 0.06


    Sum Trading At: ,Primary Metric per Adjusted Equity: ($2.222,756) M, 445.86 ,Metric Weighted per Price Range / Change, 4.56 ,Combined Weight Adj Trade Metric, 397.404 ,for +$0.9M Market Cap, for, 0.005 on .055;


    Description of Company;
    Viropro Inc., a public company, offers Contractual Research and Manufacturing Services to the biopharmaceutical industry through cell line and process development.


    The Manufacturing Processes Developed Are Out-licensed to various international partners who produce and distribute the final product. The company is currently seeking partnerships for its biosimilar (aka follow-on biologics) cell lines and manufacturing processes.


    Viropro uses patented cell lines and expression vectors that clearly out-perform the industry standards and allow partnering companies to obtain industrially competitive yields. Our technology is ideally suited for Monoclonal Antibody process development.


    Viropro, Inc. conducts operations through its subsidiaries Viropro International Inc., Biologics Process Development, Inc. and Alpha Biologics Sdn. Bhd.
    Viropro specializes in the transfer of its technologies for industrial production of biopharmaceutical therapeutic proteins for the treatment of various diseases including cancer, diabetes, hepatitis and multiple sclerosis.
    The Company’s principal objective is to provide its high-yield manufacturing process technology to biopharmaceutical companies in global markets with unmet medical and/or market needs.




    BPD, located in Poway, CA, has been providing contract laboratory services to the biotechnology and biopharmaceutical industries for more than decade. The range of services includes molecular biology, cell culture, fermentation, protein purification, frozen storage, contract manufacturing, process scale-up and consulting services. BPD has an impressive list of clients that range from university laboratories to well-known biotechnology and biopharmaceutical companies.




    Intas Biopharmaceuticals Limited is a fully integrated biopharmaceutical company based out of Ahmedabad, Gujarat, India. Since launch of biotechnology operations in May 2000, Research & Development (R&D) and Manufacturing of Biopharmaceutical products with a special focus on Oncology (Cancer) are the major thrust areas for the company. Intas Biopharmaceuticals is India's first and only biopharmaceutical company to receive European Union -Good Manufacturing Practice (EU-GMP) certification for its manufacturing facility.




    Quote Enter VPRO and Get Info @








    2006: 1.50 / Share;
    Recently off the low of .0023, and the high of 14 Cents;


    [X] Own Shares and Review the Company;
    4 Jul 2011, 09:22 AM Reply Like
Full index of posts »
Latest Followers


  • Immnuocellular Therapeutics | IMUC | Profile | Summary $IMUC http://seekingalpha.com/p/1jr2r
    Jan 21, 2014
  • Social Network play TCLN looks good today! TCLN.OB is a small cap social media company that shares ad revenues with its members
    Jun 9, 2010
More »

Latest Comments

Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.